Nexentis below Nasdaq equity rule, has 45 days

Rhea-AI Filing Summary

Nexentis Technologies Inc. (NXTS) has been notified by Nasdaq that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing under Nasdaq Listing Rule 5550(b)(1), which requires at least $2,500,000 of stockholders’ equity. Nexentis reported $1,782,000 of stockholders’ equity as of June 30, 2026 in its Form 10‑Q.

The notice does not immediately affect trading of Nexentis common stock on The Nasdaq Capital Market. The company has 45 days, until October 15, 2026, to submit a plan to regain compliance. If Nasdaq accepts the plan, Nexentis may receive up to a 180‑day extension through February 27, 2027 to restore compliance. If a plan is not accepted or compliance is not regained, Nasdaq staff would issue a delisting determination, which Nexentis could appeal to a Nasdaq Hearings Panel, staying any delisting while the appeal is pending.

Positive

• None.

Negative

• Noncompliance with Nasdaq equity standard: Stockholders’ equity was $1,782,000 as of June 30, 2026, below the $2,500,000 minimum under Nasdaq Listing Rule 5550(b)(1), creating a formal deficiency and potential delisting risk if compliance is not regained.

8-K Event Classification

Item 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

1 item

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Securities

The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.

Key Figures

Nasdaq minimum stockholders’ equity requirement: $2,500,000 Nexentis stockholders’ equity: $1,782,000 Deficiency plan period: 45 days +2 more

5 metrics

Nasdaq minimum stockholders’ equity requirement $2,500,000 Required under Nasdaq Listing Rule 5550(b)(1) for continued listing

Nexentis stockholders’ equity $1,782,000 As of June 30, 2026, reported in Form 10‑Q

Deficiency plan period 45 days Time from August 31, 2026 to submit compliance plan, until October 15, 2026

Maximum extension period 180 days Potential extension through February 27, 2027 if plan is accepted

Trading market The Nasdaq Capital Market Current listing venue for Nexentis common stock

Key Terms

stockholders’ equity, Nasdaq Listing Rule 5550(b)(1), continued listing, Nasdaq Hearings Panel

4 terms

stockholders’ equity financial

"the Company’s stockholders’ equity as of June 30, 2026 was $1,782,000"

Stockholders’ equity is the portion of a company’s value that belongs to its owners after subtracting what the company owes from what it owns — like the equity in a house after paying the mortgage. For investors it shows the company’s net worth and can indicate financial strength, a cushion against losses, and the amount potentially available to support dividends or reinvestment; tracking changes helps assess whether the business is building or eroding owner value.

Nasdaq Listing Rule 5550(b)(1) regulatory

"minimum stockholders’ equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1)"

continued listing regulatory

"minimum stockholders’ equity requirement for continued listing on Nasdaq"

When a stock receives a "continued listing," it means the exchange has decided the company’s shares will remain tradable on that market after a review or challenge, often because the company met certain requirements or corrective steps. For investors this matters because continued listing preserves liquidity and access to buy or sell the stock—think of it as a store passing an inspection so customers can keep shopping rather than being forced to close.

Nasdaq Hearings Panel regulatory

"entitled to request a hearing before a Nasdaq Hearings Panel"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What Nasdaq issue did Nexentis Technologies Inc. (NXTS) disclose?

Nexentis disclosed that Nasdaq notified the company it no longer meets the minimum $2,500,000 stockholders’ equity requirement for continued listing under Nasdaq Listing Rule 5550(b)(1), based on equity of $1,782,000 reported as of June 30, 2026.

What was Nexentis (NXTS) stockholders’ equity at June 30, 2026?

As reported in its Form 10‑Q, Nexentis had stockholders’ equity of $1,782,000 as of June 30, 2026, compared with the $2,500,000 minimum required for continued listing on The Nasdaq Capital Market.

Does the Nasdaq deficiency notice immediately affect trading of NXTS stock?

No. The company states the Nasdaq deficiency letter has no immediate impact on the listing of its common stock on The Nasdaq Capital Market while it pursues a compliance plan and any available extensions or hearings.

How long does Nexentis (NXTS) have to submit a Nasdaq compliance plan?

Nexentis has 45 calendar days from the August 31, 2026 letter, or until October 15, 2026, to submit a plan to regain compliance with the Nasdaq stockholders’ equity requirement.

What extension period could Nexentis (NXTS) receive to regain Nasdaq compliance?

If Nasdaq staff accepts the company’s compliance plan, Nexentis may be granted an extension of up to 180 calendar days from the August 31, 2026 notice, through February 27, 2027, to regain compliance with the stockholders’ equity requirement.

What happens if Nexentis (NXTS) cannot regain Nasdaq compliance?

If the plan is not accepted or compliance is not regained within any extension, Nasdaq staff would issue a delisting determination. Nexentis would then be entitled to request a hearing before a Nasdaq Hearings Panel, which would stay any delisting action while the hearing process proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/03/2026 - 04:13 PM EDT Accepted by SEC EDGAR 09/03/2026 - 04:05 PM EDT Learn about SEC filing dates

false 0001789192 0001789192 2026-08-31 2026-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 31, 2026

Nexentis Technologies Inc.

(Exact name of registrant as specified in its charter)

Nevada		001-40403		26-4684680
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

Pinhas Sapir St. 3, Kiryat HaMada Ness Ziona, Israel		7403626
(Address of principal executive offices)		(Zip Code)

(347) 468 9583

(Registrant’s telephone number, including area code)

N/A

(Former Name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of exchange on which registered
Common Stock, par value $0.0001 per share		NXTS		The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

On August 31, 2026, Nexentis Technologies Inc. (the “Company”) received a letter (“Letter”) from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Capital Market (“Nasdaq”) notifying the Company that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the period ended June 30, 2026 (the “Form 10-Q”) is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on Nasdaq under Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement”). As reported on the Form 10-Q, the Company’s stockholders’ equity as of June 30, 2026 was $1,782,000. The Letter has no immediate impact on the listing of the Company’s common stock on Nasdaq.

In accordance with the Nasdaq Listing Rules, the Company has 45 calendar days, or until October 15, 2026, to submit a plan to regain compliance with the Stockholders’ Equity Requirement (the “Compliance Plan”), which the Company plans to timely submit for the Staff’s consideration. If the Compliance Plan is accepted, the Staff may grant the Company an extension period of up to 180 calendar days from the date of the Letter, through February 27, 2027, to regain compliance with the Stockholders’ Equity Requirement.

There can be no assurance that the Staff will accept the Compliance Plan or, if accepted, that the Company will be able to evidence compliance with the Stockholders’ Equity Requirement during any extension period that the Staff may grant. If the Staff does not accept the Compliance Plan or if the Company is unable to regain compliance within any extension period granted by the Staff, the Staff would be required to issue a delisting determination. The Company would, at that time, be entitled to request a hearing before a Nasdaq Hearings Panel to present its Compliance Plan to regain compliance and to request a further extension period to regain compliance with the Stockholders’ Equity Requirement. The request for a hearing would stay any delisting action by the Staff.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Nexentis Technologies Inc.
Date: September 3, 2026	By:	/s/ David Palach
	Name:	David Palach
	Title:	Chief Executive Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL SCHEMA FILE 3.0 KB
• EX-101 XBRL LABEL FILE 33.4 KB
• EX-101 XBRL PRESENTATION FILE 21.8 KB